1. A Phase II, single-arm study of nivolumab in patients with metastatic or unresectable urothelial cancer who have progressed following treatment with a platinum agent. (4th November 2015) Authors: Sharma, Padmanee; Grimm, Marc-Oliver; Galsky, Matthew D; Baron, Ari; Bracarda, Sergio; Siefker-Radtke, Arlene; Lambert, Alexandre; Azrilevich, Alex; Retz, Margitta Journal: Journal for immunotherapy of cancer Issue: Volume 3(2015)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Phase II, single-arm study of nivolumab in patients with metastatic or unresectable urothelial cancer who have progressed following treatment with a platinum agent. Issue 2 (December 2015) Authors: Sharma, Padmanee; Grimm, Marc-Oliver; Galsky, Matthew; Baron, Ari; Bracarda, Sergio; Siefker-Radtke, Arlene; Lambert, Alexandre; Azrilevich, Alex; Retz, Margitta Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial. Issue 10126 (24th March 2018) Authors: Kudo, Masatoshi; Finn, Richard S; Qin, Shukui; Han, Kwang-Hyub; Ikeda, Kenji; Piscaglia, Fabio; Baron, Ari; Park, Joong-Won; Han, Guohong; Jassem, Jacek; Blanc, Jean Frederic; Vogel, Arndt; Komov, Dmitry; Evans, T R Jeffry; Lopez, Carlos; Dutcus, Corina; Guo, Matthew; Saito, Kenichi; Kraljevic, S... Journal: Lancet Issue: Volume 391:Issue 10126(2018) Page Start: 1163 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial. Issue 3 (March 2017) Authors: Sharma, Padmanee; Retz, Margitta; Siefker-Radtke, Arlene; Baron, Ari; Necchi, Andrea; Bedke, Jens; Plimack, Elizabeth R; Vaena, Daniel; Grimm, Marc-Oliver; Bracarda, Sergio; Arranz, José Ángel; Pal, Sumanta; Ohyama, Chikara; Saci, Abdel; Qu, Xiaotao; Lambert, Alexandre; Krishnan, Suba; Azrilevich... Journal: Lancet oncology Issue: Volume 18:Issue 3(2017:Mar.) Page Start: 312 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial. Issue 7 (July 2021) Authors: Powles, Thomas; Csőszi, Tibor; Özgüroğlu, Mustafa; Matsubara, Nobuaki; Géczi, Lajos; Cheng, Susanna Y-S; Fradet, Yves; Oudard, Stephane; Vulsteke, Christof; Morales Barrera, Rafael; Fléchon, Aude; Gunduz, Seyda; Loriot, Yohann; Rodriguez-Vida, Alejo; Mamtani, Ronac; Yu, Evan Y; Nam, Kijoeng; Imai... Journal: Lancet oncology Issue: Volume 22:Issue 7(2021) Page Start: 931 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗